Impacts of COVID-19 on Clinical Trials Costs to Patients: Environmental Scan

This environmental scan examines the types of direct and indirect costs to patients associated with clinical trial participation. It also explores the effect of COVID-19 on costs to patients, including cost implications of clinical trial innovations widely implemented during COVID-19 and other efforts to increase diversity of clinical trials.